 |
MorphoSys AG
MOR
|
-0.591 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Arbutus Biopharma Corporation
ABUS
|
-3.41 |
$ 4.79 |
- |
$ 795 M |
Canada |
 |
Aclaris Therapeutics
ACRS
|
-9.24 |
$ 3.04 |
- |
$ 235 M |
USA |
 |
BioVie
BIVI
|
-0.244 |
$ 1.27 |
- |
$ 1.88 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
-4.27 |
- |
- |
$ 1.01 B |
USA |
 |
Alpine Immune Sciences
ALPN
|
-5.5 |
- |
- |
$ 2.17 B |
USA |
 |
AlloVir
ALVR
|
-3.61 |
- |
4.14 % |
$ 49.1 M |
USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 |
- |
- |
$ 40.3 B |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-43.1 |
$ 0.18 |
- |
$ 392 M |
Israel |
 |
Aptorum Group Limited
APM
|
29.4 |
$ 1.17 |
- |
$ 6.38 M |
China |
 |
Ampio Pharmaceuticals
AMPE
|
-20.4 |
- |
-11.43 % |
$ 502 K |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Applied Molecular Transport
AMTI
|
-1.19 |
- |
- |
$ 10.1 M |
USA |
 |
Midatech Pharma plc
MTP
|
0.796 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Celldex Therapeutics
CLDX
|
0.185 |
$ 26.83 |
- |
$ 1.73 M |
USA |
 |
Ascendis Pharma A/S
ASND
|
-15.7 |
$ 212.81 |
- |
$ 5 B |
Danmark |
 |
Aptevo Therapeutics
APVO
|
-2.13 |
$ 0.93 |
- |
$ 257 K |
USA |
 |
Cellectar Biosciences
CLRB
|
1.31 |
$ 2.76 |
- |
$ 33.7 M |
USA |
 |
Alterity Therapeutics Limited
ATHE
|
-0.994 |
$ 3.1 |
0.16 % |
$ 7.46 B |
Australia |
 |
Biophytis SA
BPTS
|
-17.6 |
- |
-13.47 % |
$ 169 M |
France |
 |
Athersys
ATHX
|
0.437 |
- |
3.77 % |
$ 22.4 M |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
14 |
- |
- |
- |
Russia |
 |
Avenue Therapeutics
ATXI
|
0.871 |
- |
-52.27 % |
$ 4.45 M |
USA |
 |
CureVac N.V.
CVAC
|
-7.74 |
$ 4.31 |
- |
$ 802 M |
Germany |
 |
ARCA biopharma
ABIO
|
1.84 |
- |
1052.0 % |
$ 415 M |
USA |
 |
AVROBIO
AVRO
|
0.957 |
- |
1083.1 % |
$ 745 M |
USA |
 |
Acasti Pharma
ACST
|
1.8 |
- |
4.01 % |
$ 150 M |
Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
-12.7 |
- |
-15.15 % |
$ 60.3 M |
Britain |
 |
BioDelivery Sciences International
BDSI
|
8 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Albireo Pharma
ALBO
|
-3.38 |
- |
-0.23 % |
$ 916 M |
USA |
 |
BioNTech SE
BNTX
|
4.1 |
$ 95.03 |
- |
$ 27.2 B |
Germany |
 |
Amphastar Pharmaceuticals
AMPH
|
17.3 |
$ 26.81 |
- |
$ 1.3 B |
USA |
 |
BeiGene, Ltd.
BGNE
|
-208 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Anika Therapeutics
ANIK
|
38.7 |
$ 9.48 |
- |
$ 139 M |
USA |
 |
Bellicum Pharmaceuticals
BLCM
|
1.13 |
- |
-9.72 % |
$ 5.89 M |
USA |
 |
Berkeley Lights
BLI
|
-16.9 |
- |
-7.31 % |
$ 87 M |
USA |
 |
bluebird bio
BLUE
|
-0.805 |
- |
- |
$ 546 M |
USA |
 |
Dynavax Technologies Corporation
DVAX
|
12.8 |
$ 15.38 |
- |
$ 2 B |
USA |
 |
Arena Pharmaceuticals
ARNA
|
-9.01 |
- |
-6.81 % |
$ 3.04 B |
USA |
 |
Acer Therapeutics
ACER
|
-3.39 |
- |
2.71 % |
$ 14 M |
USA |
 |
Calithera Biosciences
CALA
|
-7.96 |
- |
-10.95 % |
$ 876 K |
USA |
 |
Axon Enterprise
AXON
|
-63.9 |
$ 591.15 |
- |
$ 44.8 B |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.785 |
- |
- |
$ 7.46 M |
Israel |
 |
Eton Pharmaceuticals
ETON
|
-53 |
$ 16.99 |
- |
$ 436 M |
USA |
 |
Aytu BioScience
AYTU
|
-1.92 |
$ 2.53 |
-0.39 % |
$ 15.9 M |
USA |
 |
AstraZeneca PLC
AZN
|
76.5 |
$ 92.45 |
- |
$ 96.9 B |
Britain |
 |
Acorda Therapeutics
ACOR
|
0.777 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Catalyst Biosciences
CBIO
|
0.34 |
$ 12.37 |
2.06 % |
$ 814 M |
USA |
 |
Brickell Biotech
BBI
|
0.668 |
- |
-5.38 % |
$ 6.06 M |
USA |
 |
Foghorn Therapeutics
FHTX
|
-11.7 |
$ 5.4 |
- |
$ 296 M |
USA |